Tackling the Hidden Crisis: Smart Beds Cut Severe ECMO Pressure Injuries

PALO ALTO, Calif. – October 01, 2026 — In the high-stakes environment of the intensive care unit, saving a patient’s life can sometimes inadvertently cause secondary trauma. For patients placed on extracorporeal membrane oxygenation (ECMO)—a highly invasive life-support machine that replaces the function of the heart and lungs—survival often requires days or weeks of near-total immobility. This stasis creates a hidden crisis: severe, hospital-acquired pressure injuries (HAPIs), commonly known as bedsores, which can lead to massive infections, extended hospital stays, and even death.

However, newly presented real-world clinical data suggests that the intersection of dynamic perfusion technology and data analytics could fundamentally change this grim reality. At the 37th Annual Extracorporeal Life Support Organization (ELSO) 2026 Conference in Nashville, Tennessee, TurnCare, Inc. revealed striking outcomes following the implementation of its Guardian System. The retrospective study demonstrated a dramatic drop in severe pressure injuries and a measurable increase in overall ECMO patient survival, signaling a potential shift in how critical care units manage their most vulnerable populations.

The Physiological Paradox of Extracorporeal Life Support

The fundamental challenge of ECMO care lies in a physiological paradox. The treatment requires large cannulae (tubes) to be inserted into major blood vessels to route the patient's blood through an external oxygenator. Because these lines are precarious, standard nursing protocols—which typically mandate turning a patient every two hours to relieve pressure on bony prominences—are exceedingly dangerous. Dislodging an ECMO cannula is often a fatal event.

Consequently, patients remain supine for extended periods. Without movement, the continuous weight of the body compresses the vascular network, particularly around the sacral region, starving the skin and underlying tissue of oxygenated blood. Cell death begins rapidly, forming deep tissue injuries that are notoriously difficult to heal.

"Pressure injury prevention is particularly challenging for patients on ECMO, where critical illness, prolonged immobility, and the complexity of care make conventional prevention strategies difficult to implement," said Chris Linke, MHI, RN, CSSMBB, of M Health Fairview University of Minnesota Medical Center, who presented the analysis at the ELSO conference. "These findings offer an important perspective on the potential role of dynamic perfusion enhancement systems in restoring blood flow as part of a comprehensive strategy to protect vulnerable patients."

The single-center retrospective pre- and post-cohort study compared a baseline group of 317 ECMO patients (representing 2,112 ECMO days) against a cohort of 92 patients (595 ECMO days) managed with the Guardian System. The results were highly compelling. The medical center observed a 40.8% reduction in sacral-region HAPI incidence, dropping from 14.2 to 8.4 events per 1,000 ECMO days. Total HAPI incidence fell by 36.2%, and sacral-region Stage 2 injuries plummeted by an impressive 72.7%. Crucially, ECMO survival increased from 53.2% in the baseline cohort to 57.8% following the system's implementation.

Beyond Pressure Redistribution: The Shift to Dynamic Perfusion

For decades, the standard response to pressure injury prevention has been the alternating pressure mattress. These traditional Class II medical devices cyclically inflate and deflate air cells to periodically offload pressure from different parts of the body. While effective for less critical patients, they merely redistribute pressure rather than actively addressing the underlying cause of tissue death: impaired blood flow.

The Palo Alto-based medical device manufacturer took a radically different engineering approach. Instead of simply shifting weight, the Guardian System operates as a dynamic perfusion enhancement technology. It utilizes a high-precision pressure controller and anatomically aligned air chambers driven by a perpetual, non-repeating algorithm. By continuously and intelligently modifying pressure, the system avoids applying sustained or repetitive force over vulnerable areas like the sacrum.

Medical device engineers note that this continuous, non-cyclical modulation actively maintains localized blood flow rather than passively offloading it. By preventing the initial vascular compression, the technology protects against the cascade of cell death that leads to severe wounds.

"ECMO patients face an extraordinary risk of pressure injury, and the very nature of their care can make traditional prevention strategies difficult," stated Linda Seaman, MSN, BSN, CCRN, VP of Clinical Affairs at TurnCare. "These results are compelling and underscore the potential of a more dynamic approach to pressure injury prevention that addresses an underlying cause, impaired blood flow. By helping restore blood flow, we have an opportunity to better protect these vulnerable patients."

The Economics of Prevention and Compliance Tracking

Beyond the profound human cost, hospital-acquired pressure injuries represent a massive financial liability for health systems. In the United States alone, the healthcare system spends over $26.8 billion annually treating patients with HAPIs. A single severe pressure injury can cost a hospital between $20,900 and $151,700 to treat, adding an average of 4 to 6 days to a patient's stay.

Furthermore, the Centers for Medicare & Medicaid Services (CMS) classifies Stage III and IV pressure injuries as "never events." Under the Hospital-Acquired Condition Reduction Program (HACRP), CMS refuses to reimburse hospitals for the additional cost of treating these preventable conditions and can penalize hospitals with high HAPI rates by reducing their overall Medicare payments by 1%. Adding to the financial exposure, HAPIs are a leading cause of medical malpractice lawsuits, with median settlements frequently exceeding $1 million.

To address both clinical and operational challenges, the Guardian System integrates an Information Services (iS) operational insights dashboard. This software platform provides real-time visibility into therapy compliance and patient mobility goals. Nursing leaders can generate daily, weekly, or monthly unit-level reports on therapy utilization, tracking exactly how and when the system is supporting a patient.

Hospital administrators point out that this data-driven approach is invaluable. Not only does it ensure that critical care protocols are being followed without burdening nursing staff with manual logging, but it also provides an auditable digital trail of proactive care—a crucial defense against CMS penalties and potential litigation.

To lower the barrier to adoption, the company offers the technology through a utilization-based rental model rather than requiring massive upfront capital expenditures. By shifting the cost to an operational expense, health systems can bypass lengthy Value Analysis Committee (VAC) capital budget approvals, directly offsetting the rental costs with the immediate savings generated by avoiding catastrophic HAPIs.

Reshaping Critical Care Standards

The therapeutic support surface market is fiercely competitive and projected to reach $11.4 billion by 2034. It is currently dominated by massive medical technology conglomerates like Stryker, Arjo, and Baxter International (formerly Hillrom), which supply the bulk of the world's smart beds and ICU surfaces. These established players have heavily invested in automated repositioning, microclimate management, and IoT-enabled monitoring.

However, the introduction of active perfusion enhancement as a distinct, highly effective category could disrupt this landscape. The National Pressure Injury Advisory Panel (NPIAP), which sets the definitive evidence-based guidelines for pressure injury prevention, has historically emphasized manual repositioning protocols alongside support surface selection. If dynamic perfusion systems consistently demonstrate the ability to maintain tissue viability without the need for dangerous manual turns in highly acute patients, these international guidelines may eventually evolve to recommend active perfusion over passive redistribution for ECMO and other critically immobile populations.

As healthcare continues to seek solutions at the intersection of advanced biomechanics and digital analytics, technologies that can simultaneously improve survival rates, alleviate nursing burdens, and protect hospital margins will define the next era of critical care. The data emerging from Nashville suggests that the future of intensive care might not just be about keeping the heart and lungs pumping, but ensuring that every capillary continues to flow.